List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #51 to #100.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Atezolizumab (MPDL3280A) → Atezolizumab (Tecentriq)
- Atypical hemolytic-uremic syndrome → Atypical hemolytic uremic syndrome
- Atypical hemolytic uremic syndrome (aHUS) → Atypical hemolytic uremic syndrome
- Autoimmune cytopenias → Autoimmune cytopenia
- Autoimmune hemolytic anemia → Warm autoimmune hemolytic anemia
- Autoimmune hemolytic anemia (AIHA) → Autoimmune hemolytic anemia
- Autoimmune thrombocytopenic purpura (ITP) → Immune thrombocytopenia
- Avatrombopag (E5501) → Avatrombopag (Doptelet)
- Axicabtagene ciloleucel (KTE-C19) → Axicabtagene ciloleucel (Yescarta)
- Azacitidine (Onureg) → Azacitidine oral (Onureg)
- B-cell acute lymphoblastic leukaemia → B-cell acute lymphoblastic leukemia
- B-cell acute lymphoblastic leukaemia, Ph-positive → B-cell acute lymphoblastic leukemia, Ph-positive
- B-cell acute lymphoblastic leukemia, Ph-positive, pediatric → B-cell acute lymphoblastic leukemia, pediatric, Ph-positive
- BHQ880 (Anti-DKK1 Antibody) → BHQ880
- BIDMC clinical trials → Clinical trials
- BMS-275291 → Rebimastat (BMS-275291)
- BPDCN → Blastic plasmacytoid dendritic cell neoplasm
- BRAF → Malignant solid neoplasm, BRAF-mutated
- Bacillus Calmette-Guérin (BCG) → BCG vaccine
- Bacillus Calmette-Guérin (BCG, TheraCys) → BCG vaccine
- Basal cell and squamous cell skin cancer → Cutaneous basal cell carcinoma
- Basal cell carcinoma (BCC) → Cutaneous basal cell carcinoma
- Bb2121 → Idecabtagene vicleucel (Abecma)
- Bendamustine (Bendeka) → Bendamustine
- Bendamustine (Treanda) → Bendamustine
- Binimetinib (MEK162) → Binimetinib (Mektovi)
- Blinatumomab (AMG 103) → Blinatumomab (Blincyto)
- Bone cancer → Bone sarcoma
- Bosulif → Bosutinib (Bosulif)
- Bosutinib → Bosutinib (Bosulif)
- Bosutinib (SKI-606) → Bosutinib (Bosulif)
- Breast Cancer → Breast cancer
- Brigatinib (AP26113) → Brigatinib (Alunbrig)
- CAL-101 → Idelalisib (Zydelig)
- CAT-3888 (BL22) → BL22 immunotoxin (CAT-3888)
- CC-292 (AVL-292) → Spebrutinib (CC-292)
- CLL → Chronic lymphocytic leukemia
- CMML → Chronic myelomonocytic leukemia
- CNS leukaemia → CNS leukemia
- COVID-19 and cancer → COVID-19 coronavirus and cancer
- CPX-351 → Cytarabine and daunorubicin (Vyxeos)
- CRC → Colorectal cancer
- CTCL → Cutaneous T-cell lymphoma
- Cabozantinib (Cabometyx) → Cabozantinib (Cometriq)
- Cabozantinib (XL184) → Cabozantinib (Cometriq)
- Capivasertib (AZD-5363) → Capivasertib (Truqap)
- Caplacizumab → Caplacizumab (Cablivi)
- Caplacizumab (ALX-0081) → Caplacizumab (Cablivi)
- Carfilzomib → Carfilzomib (Kyprolis)
- Carfilzomib (PR-171) → Carfilzomib (Kyprolis)